Adage Capital Partners Gp, L.L.C. Biomea Fusion, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $56.4 Billion
- Q2 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 500,000 shares of BMEA stock, worth $1.34 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500,000
Previous 500,000
-0.0%
Holding current value
$1.34 Million
Previous $1.07 Million
15.49%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BMEA
# of Institutions
99Shares Held
23.2MCall Options Held
1.08MPut Options Held
359K-
Heights Capital Management, Inc San Francisco, CA3.84MShares$10.3 Million1.84% of portfolio
-
Cormorant Asset Management, LP Boston, MA3.57MShares$9.53 Million0.65% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$6.26 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY2.05MShares$5.47 Million1.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$5.02 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $78.2M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...